Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-27

FDA Approved: PERSERIS — Original Application (Indivior Inc.)

View source ↗

Summary

The FDA approved Perseris (risperidone subcutaneous long-acting injectable) under its original NDA for adults with schizophrenia, introducing a monthly injectab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PERSERIS (RISPERIDONE)

Snippet

ORIG AP for PERSERIS (RISPERIDONE)